| Design and validation of a histological scoring system for nonalcoholic fatty liver disease DE Kleiner, EM Brunt, M Van Natta, C Behling, MJ Contos, OW Cummings, ... Hepatology 41 (6), 1313-1321, 2005 | 11183 | 2005 |
| Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis AJ Sanyal, N Chalasani, KV Kowdley, A McCullough, AM Diehl, NM Bass, ... New England Journal of Medicine 362 (18), 1675-1685, 2010 | 3881 | 2010 |
| Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease P Angulo, DE Kleiner, S Dam-Larsen, LA Adams, ES Bjornsson, ... Gastroenterology 149 (2), 389-397. e10, 2015 | 2989 | 2015 |
| MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease M Eslam, AJ Sanyal, J George, A Sanyal, B Neuschwander-Tetri, ... Gastroenterology 158 (7), 1999-2014. e1, 2020 | 2918 | 2020 |
| Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial BA Neuschwander-Tetri, R Loomba, AJ Sanyal, JE Lavine, ML Van Natta, ... The Lancet 385 (9972), 956-965, 2015 | 2511 | 2015 |
| Comprehensive and integrative genomic characterization of hepatocellular carcinoma A Ally, M Balasundaram, R Carlsen, E Chuah, A Clarke, N Dhalla, RA Holt, ... Cell 169 (7), 1327-1341. e23, 2017 | 2038 | 2017 |
| Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis K Promrat, DE Kleiner, HM Niemeier, E Jackvony, M Kearns, JR Wands, ... Hepatology 51 (1), 121-129, 2010 | 1673 | 2010 |
| Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial JE Lavine, JB Schwimmer, ML Van Natta, JP Molleston, KF Murray, ... Jama 305 (16), 1659-1668, 2011 | 1357 | 2011 |
| Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings EM Brunt, DE Kleiner, LA Wilson, P Belt, BA Neuschwander‐Tetri, ... Hepatology 53 (3), 810-820, 2011 | 1354 | 2011 |
| Quantitative zymography: detection of picogram quantities of gelatinases DE Kleiner, WG Stetlerstevenson Analytical biochemistry 218 (2), 325-329, 1994 | 1236 | 1994 |
| Matrix metalloproteinases and metastasis DE Kleiner, WG Stetler-Stevenson Cancer chemotherapy and pharmacology 43, S42-S51, 1999 | 1147 | 1999 |
| A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis K Promrat, G Lutchman, GI Uwaifo, RJ Freedman, A Soza, T Heller, E Doo, ... Hepatology 39 (1), 188-196, 2004 | 1015 | 2004 |
| AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease ME Rinella, BA Neuschwander-Tetri, MS Siddiqui, MF Abdelmalek, ... Hepatology 77 (5), 1797-1835, 2023 | 989 | 2023 |
| Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte–associated antigen 4 KE Beck, JA Blansfield, KQ Tran, AL Feldman, MS Hughes, RE Royal, ... Journal of Clinical Oncology 24 (15), 2283-2289, 2006 | 949 | 2006 |
| Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4 HS Kuehn, W Ouyang, B Lo, EK Deenick, JE Niemela, DT Avery, ... Science 345 (6204), 1623-1627, 2014 | 922 | 2014 |
| Endpoints and clinical trial design for nonalcoholic steatohepatitis AJ Sanyal, EM Brunt, DE Kleiner, KV Kowdley, N Chalasani, JE Lavine, ... Hepatology 54 (1), 344-353, 2011 | 867 | 2011 |
| Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease K De Hepatology 41, 1313-1321, 2005 | 853 | 2005 |
| Early-onset stroke and vasculopathy associated with mutations in ADA2 Q Zhou, D Yang, AK Ombrello, AV Zavialov, C Toro, AV Zavialov, ... New England Journal of Medicine 370 (10), 911-920, 2014 | 850 | 2014 |
| Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis WG Stetler‐Stevenson, LA Liotta, DE Kleiner Jr The FASEB Journal 7 (15), 1434-1441, 1993 | 827 | 1993 |
| Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma AG Duffy, SV Ulahannan, O Makorova-Rusher, O Rahma, H Wedemeyer, ... Journal of hepatology 66 (3), 545-551, 2017 | 819 | 2017 |